v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (777,148) $ (737,778)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 9,268 389
Amortization of capitalized research and development costs 305,413
Foreign exchange differences 181
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (3,676) 29,108
Decrease (increase) in prepaid expenses and other current assets 2,799 (43,804)
Increase in accounts payable and accrued liabilities 144,739 262,009
Increase in deferred revenues 73,616
Increase in current tax liability 15,560
Net cash used in operating activities (244,808) (474,516)
CASH FLOWS FROM INVESTING ACTIVITIES    
Increase in long-term deposit (22,862)
Capitalized research and development costs (430,398) (522,626)
Purchase of property and equipment (28,368) (14,935)
Net cash used in investing activities (458,766) (560,423)
CASH FLOWS FROM FINANCING ACTIVITIES    
Increase in advance payable – related party 652,629 8,000
Proceeds from sale of Class A common stock 1,100,000
Net cash provided by financing activities 652,629 1,108,000
Net (decrease) increase in cash and cash equivalents (50,945) 73,061
Cash and cash equivalents, beginning of the year 77,200 9,929
Cash and cash equivalents, end of the year $ 26,255 $ 82,990